FLIXONASE

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug FLIXONASE contains one active pharmaceutical ingredient (API):

1 Fluticasone UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. Read about Fluticasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FLIXONASE Nasal spray	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
FLIXONASE Nasal drops	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AD08	Fluticasone	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AD Corticosteroids
Discover more medicines within R01AD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510603001172315, 510603002179313
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29604-1-01-11
Country: EE	Ravimiamet	Identifier(s): 1007233, 1173620, 1643228, 1762950
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60483, 62771, R-2948IP
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 018285, 021100, 431809
Country: FR	Base de données publique des médicaments	Identifier(s): 61748649
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138764, 142336, 181549, 196125, 28109, 381341, 43807
Country: HK	Department of Health Drug Office	Identifier(s): 47400
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-653844542
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1073034, 1084743
Country: MT	Medicines Authority	Identifier(s): AA460/00801, MA192/04101, PI1438/03901A, PI908/02102A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 441M95
Country: NG	Registered Drug Product Database	Identifier(s): 04-2629
Country: NL	Z-Index G-Standaard	Identifier(s): 14236664
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 67202, 72346
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5254
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100024517, 100193504
Country: SG	Health Sciences Authority	Identifier(s): 07090P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8573021
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522543014
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/21.5.1/0329, X/21.5.1/359